KBC Group NV increased its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 1,803.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 46,181 shares of the company's stock after purchasing an additional 43,755 shares during the quarter. KBC Group NV's holdings in Ryan Specialty were worth $2,963,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in the business. Hollencrest Capital Management bought a new position in shares of Ryan Specialty in the 3rd quarter worth about $25,000. Assetmark Inc. acquired a new stake in Ryan Specialty during the third quarter worth about $34,000. Quarry LP lifted its holdings in Ryan Specialty by 109.3% in the third quarter. Quarry LP now owns 808 shares of the company's stock worth $54,000 after acquiring an additional 422 shares during the last quarter. GAMMA Investing LLC boosted its stake in Ryan Specialty by 106.4% in the third quarter. GAMMA Investing LLC now owns 1,249 shares of the company's stock valued at $83,000 after acquiring an additional 644 shares during the period. Finally, Signaturefd LLC grew its holdings in shares of Ryan Specialty by 12.3% during the third quarter. Signaturefd LLC now owns 1,347 shares of the company's stock valued at $89,000 after purchasing an additional 148 shares during the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.
Ryan Specialty Price Performance
Shares of RYAN stock traded up $1.09 during midday trading on Tuesday, reaching $68.54. 1,031,723 shares of the company were exchanged, compared to its average volume of 1,019,906. The company's 50 day moving average price is $66.52 and its two-hundred day moving average price is $66.72. The company has a market cap of $17.95 billion, a P/E ratio of 89.01, a PEG ratio of 1.16 and a beta of 0.72. Ryan Specialty Holdings, Inc. has a 12 month low of $42.34 and a 12 month high of $75.97. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.
Analyst Ratings Changes
Several analysts recently issued reports on RYAN shares. The Goldman Sachs Group raised their price target on Ryan Specialty from $64.00 to $72.00 and gave the stock a "neutral" rating in a report on Wednesday, October 9th. Morgan Stanley assumed coverage on Ryan Specialty in a research report on Thursday, December 5th. They issued an "overweight" rating and a $90.00 target price on the stock. Bank of America boosted their price target on shares of Ryan Specialty from $75.00 to $84.00 and gave the company a "buy" rating in a report on Thursday, October 10th. Barclays increased their price objective on shares of Ryan Specialty from $76.00 to $88.00 and gave the stock an "overweight" rating in a report on Thursday, November 21st. Finally, Wells Fargo & Company reduced their target price on shares of Ryan Specialty from $68.00 to $64.00 and set an "equal weight" rating for the company in a research note on Tuesday, January 14th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and six have given a buy rating to the company's stock. Based on data from MarketBeat, Ryan Specialty currently has a consensus rating of "Hold" and an average target price of $74.40.
Check Out Our Latest Analysis on Ryan Specialty
Insider Activity at Ryan Specialty
In related news, EVP Mark Stephen Katz sold 14,790 shares of Ryan Specialty stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the transaction, the executive vice president now directly owns 12,386 shares of the company's stock, valued at $884,236.54. The trade was a 54.42 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Nicholas Dominic Cortezi sold 31,409 shares of the company's stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $65.64, for a total transaction of $2,061,686.76. Following the completion of the sale, the director now directly owns 2,697 shares of the company's stock, valued at $177,031.08. The trade was a 92.09 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 338,296 shares of company stock worth $22,463,709 over the last quarter. 11.10% of the stock is currently owned by company insiders.
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Read More
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
